Literature DB >> 1262050

Complement activation by interaction of polyanions and polycations.

B A Fiedel, R Rent, R Myhrman, H Gewurz.   

Abstract

Interactions between heparin and protamine in normal human serum previously were found to activate the primary complement pathway and deplete the early-acting complement components. In the present investigation, the role of heparin-protamine complexes, immunoglobulins, C1q and C1-INH in this interaction was studied. Heparin and protamine, like antibody and antigen, were found to combine in multiple proportions; those proportions which resulted in optimal precipitation also induced maximal C consumption. Complexes formed in serum contained C1q and IgG, but the amount of C1q was insufficient to account for the total depletion of C1 haemolytic activity, and immunoglobulins were not required for activation of complement to occur: maximal consumption was observed in immunoabsorbed hypogammaglobulinaemic sera in which IgG, IgM and IgA were undetectable (less than 5, less than 10 and less than 7 mug/ml, respectively). Purified C1q aggregated heparin-protamine complexes formed or forming in the presence or absence of serum. The ability to induce maximal C consumption was rapidly lost as heparin and protamine interacted, and complexes preformed either in serum or buffer, or supernates thereof, were relatively ineffective in complement consumption. Thus, the consumption of complement seems to occur via transient reactivity with C1,probably at the level of C1q. It seems to be limited by the ability of free heparin to potentiate the activity of C1-INH, and perhaps also by its direct effect upon the early acting C components. These experiments support the concept that complement activation by interactions between polyelectrolytes such as heparin and protamine, like interactions between the antibodies and antigens, may have a role in the initiation of inflammatory reactions by direct activation of the complement system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262050      PMCID: PMC1444977     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Studies on the non-specific precipitation of basic serum proteins with gamma-glutamyl polypeptides.

Authors:  C G LEONARD; C B THORNE
Journal:  J Immunol       Date:  1961-08       Impact factor: 5.422

2.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

3.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

4.  Agglutinating activity of the complement component C'1q in the F-II latex fixation test.

Authors:  R W Ewald; A F Schubart
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

5.  Insulin and IgG complexes. An immunologic bypass for complement activation.

Authors:  J W Cantrell; R M Stroud; K M Pruitt
Journal:  Diabetes       Date:  1972-08       Impact factor: 9.461

6.  Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.

Authors:  R Rent; N Ertel; R Eisenstein; H Gewurz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

8.  Enhanced phagocytic capacity. The biologic basis for the elevated histochemical nitroblue tetrazolium reaction.

Authors:  C E McCall; L R DeChatelet; R Butler; D Brown
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

9.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.

Authors:  V H Donaldson
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  7 in total

1.  Influence of the electric charge of the antigen and the immune complex (IC) lattice on the IC activation of human complement.

Authors:  M A Michelin; L S P Crott; A I Assis-Pandochi; T M Coimbra; J E Teixeira; J E Barbosa
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

2.  Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces β-amyloid deposits in a transgenic mouse model of Alzheimer's disease.

Authors:  Mohamed Mohamed Haroon; Kamal Saba; Venkata Harshavardhan Boddedda; Jerald Mahesh Kumar; Anant Bahadur Patel; Vijaya Gopal
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

3.  Activation of the alternative complement pathway by a streptococcal lipoteichoic acid.

Authors:  B A Fiedel; R W Jackson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  C1q binding activity in the sera of patients with chronic lung diseases.

Authors:  K M Cooper; M Moore; A M Hilton
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

5.  Modulation of the formation of the human amplification C3 convertase of complement by polycations.

Authors:  F Maillet; M D Kazatchkine
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

6.  Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.

Authors:  M Loos; D Bitter-Suermann
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

7.  Novel Immunoassay for Complement Activation by PF4/Heparin Complexes.

Authors:  Sanjay Khandelwal; Alexandra M Johnson; Jian Liu; David Keire; Cynthia Sommers; Joann Ravi; Grace M Lee; John D Lambris; Edimara S Reis; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2018-06-30       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.